Having PNH can put both the mother and baby at risk. Risks to the mother include blood clots, preeclampsia, and a need for blood transfusions. Blood-thinning drugs like Coumadin reduce the risk of ...

China has become the first country in the world to approve Roche’s anti-complement C5 antibody crovalimab, the only treatment for the rare disorder paroxysmal nocturnal haemoglobinuria (PNH ...

The mainstay of therapy for the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH) is Alexion's infusion therapy Soliris, but Novartis' iptacopan could provide an oral option after ...